Harnessing hepatitis B core-related antigen measurement to optimize posttreatment monitoring
Clinical and Molecular Hepatology · 2024
DOI: 10.3350/cmh.2024.0101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, 2024. Verfasst von Ying-Nan Tsai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Hepatitis B, Hepatitis B, Chronic. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Gilead Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan.
- School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
- Department of Public Health, National Cheng Kung University, College of Medicine, Tainan, Taiwan.
- Division of Gastroenterology and Hepatology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
Förderung
- Gilead Sciences
Zitieren
APA
Tsai, Y. N., Wu, J. L., & Hsu, Y. C. (2024). Harnessing hepatitis B core-related antigen measurement to optimize posttreatment monitoring. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2024.0101
Vancouver
Tsai YN, Wu JL, Hsu YC. Harnessing hepatitis B core-related antigen measurement to optimize posttreatment monitoring. Clinical and Molecular Hepatology. 2024. doi:10.3350/cmh.2024.0101
BibTeX
@article{Tsai2024,
author = {Tsai, Ying-Nan and Wu, Jia-Ling and Hsu, Yao-Chun},
title = {Harnessing hepatitis B core-related antigen measurement to optimize posttreatment monitoring},
journal = {Clinical and Molecular Hepatology},
year = {2024},
doi = {10.3350/cmh.2024.0101}
}
EUVIMED